Serna Bio Analysis: $0.1M Raised
What is Serna Bio?
Serna Bio is an AI-enabled drug discovery company focused on developing small molecules that target RNA. Their approach shifts the traditional protein-focused drug development paradigm to RNA, allowing for a broader range of drug targets. This innovation aims to address diseases with high unmet medical needs by modulating translation and splicing of challenging targets.
Employees
1-10
Industry
AI/ML, Biotech, HealthTech
Product Features & Capabilities
- AI-driven platform for RNA-small molecule interaction analysis
- Rational design of selective small molecules
- Massively multiplexed screening for drug discovery
- Targeting non-coding RNA and undruggable proteins
- Customizable solutions for challenging drug targets.
